Don’t Leave Your Exit to Chance: Why IP Strategy is the Foundation of the “End Game”

By Emily Chamberlain, Niklas Mattsson | Posted on May 18, 2026

What separates a successful life science exit from a missed opportunity? Often, it isn’t just the quality of the science, but the timing and precision of the IP strategy. At the recent “The End Game” event, hosted by Ventures Accelerated in Stockholm, AWA’s Niklas Mattsson and a panel of international investors, including Josefine Persson (HealthCap),...